China
1.1
No.114 changsheng street, Shijiazhuang
Add Favorite
Report Supplier
Business Description
Depai Veterinary Medicine Import & Export Co., Ltd is a franchise veterinary medicine import and export company which is a subsidiary company of HeXin Group in China. After more than 15 years of development, HeXin Group has been covering animal health products, day-old chicks production, ducks production, feed and other fields. It has 6 subsidiary companies including Pharmaceutical Factory, Duck production Factory, Feed and Chick production Factory, and veterinary medicine import & export company which is called Depai. HeXin Group located in Luquan High-tech Development Zone of Hebei, China, has over 30, 000 square meters buildings. It has been founded an international standard GMP workshop (7450 square meters), and owned 14 production lines, which can produce 11 series: including pelvis, powder, premix, granules (including traditional Chinese medicine extraction), tablets (including traditional Chinese medicine extracts), oral solution (containing Chinese herb extracts), intravenous injection of the final mass sterilization agents, final sterilization of small volume injections (including traditional Chinese medicine extraction) the final mass sterilization of non-intravenous injection, disinfectants and pesticides, and produce over 100 medicines. Our product are saled in more than twenty provinces of China Market, and we also have exported to South Korea, Southeast Asia and Africa such as Sudan, Ethiopia and others.
Business Overview
Avg Response Time
≤ 1h
Export Capabilities
Declared by supplierDepai Veterinary Medicine Import & Export C... has been exporting since 2011.
Export start year
2011
Trade Capabilities
Business Terms
Trade Ability
Medical Injections market insight
Across Medical & HealthCare, the wider group Medical Injections belongs to, Freshdi lists 9 active supply listings from 9 suppliers in 6 countries, as of 17 November 2026. Medical Injections belongs to Medical & HealthCare, whose suppliers on Freshdi come from 6 countries, led by India at 22.2%, as of 17 November 2026. In the 30 days to 17 November 2026, buyer inquiries on Freshdi across Medical & HealthCare, the group Medical Injections belongs to, rose 100% against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.
